Shares News

Autolus IPO gives welcome lift to Neil Woodford's under pressure Patient Capital Trust featured picture

Autolus IPO gives welcome lift to Neil Woodford's under pressure Patient Capital Trust

Investment trusts Woodford Patient Capital (WPCT) and Syncona (SYNC) get a major boost as the initial public offering (IPO) of portfolio company Autolus was priced at the top of the $15 to $17 range. Autolus is a gene therapy developer at the cutting edge of cancer treatment. It is working on Chimeric Antigen Receptor therapies for white blood cells called T-cells, or CAR-T therapies. The ...
Chemring moves away from low margin products to higher margin sophisticated devices featured picture

Chemring moves away from low margin products to higher margin sophisticated devices

Defence company Chemring (CHG) has had a positive first half to 2018 heled by a higher operating margin of 7.9% amid an increased contribution from its countermeasures division. This helped drive underlying pre-tax profit up 31% to £14.8m despite a 8% dip in revenues as the company moves away from its lower margin ‘Energetics’ division, essentially ammunition. The company has also ...
Showing 1 to 10 of 4,990